Literature DB >> 11058425

Body temperature as a risk factor for Alzheimer's disease.

A Holtzman1, E W Simon.   

Abstract

A number of risk factors underlie the development of Alzheimer's disease. We propose low body temperature is also implicated. This is based on the belief that low temperature influences the biomechanics of the disease and promotes its development. Support for this hypothesis is found in a consideration of temperature effects on the disease process, in anecdotal observations and from our studies of people with Down syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058425     DOI: 10.1054/mehy.2000.1085

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Impairment of Rat Spatial Learning and Memory in a New Model of Cold Water-Induced Chronic Hypothermia: Implication for Alzheimer's Disease.

Authors:  Mohammad Mahdi Ahmadian-Attari; Leila Dargahi; Mahmoud Mosaddegh; Mohammad Kamalinejad; Behzad Khallaghi; Fatemeh Noorbala; Abolhassan Ahmadiani
Journal:  Neurotox Res       Date:  2015-03-18       Impact factor: 3.911

2.  Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.

Authors:  Emmanuel Planel; Alexis Bretteville; Li Liu; Laszlo Virag; Angela L Du; Wai Haung Yu; Dennis W Dickson; Robert A Whittington; Karen E Duff
Journal:  FASEB J       Date:  2009-03-11       Impact factor: 5.191

3.  Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo.

Authors:  Emmanuel Planel; Pavan Krishnamurthy; Tomohiro Miyasaka; Li Liu; Mathieu Herman; Asok Kumar; Alexis Bretteville; Helen Y Figueroa; Wai Haung Yu; Robert A Whittington; Peter Davies; Akihiko Takashima; Ralph A Nixon; Karen E Duff
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

4.  Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

Authors:  Emmanuel Planel; Tomohiro Miyasaka; Thomas Launey; De-Hua Chui; Kentaro Tanemura; Shinji Sato; Ohoshi Murayama; Koichi Ishiguro; Yoshitaka Tatebayashi; Akihiko Takashima
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 5.  Effect of the inhaled anesthetics isoflurane, sevoflurane and desflurane on the neuropathogenesis of Alzheimer's disease (review).

Authors:  Jue Jiang; Hong Jiang
Journal:  Mol Med Rep       Date:  2015-03-04       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.